Reversal agents are defined as any drug used to counteract the pharmacologic effects of another drug. Several pharmacologic antagonists serve as essential drugs in the contemporary practices of sedation providers and anesthesiologists. Reversal or “antidote” drugs, such as flumazenil and naloxone, are often used in unintentional overdose situations involving significant benzodiazepine- and/or opioid-induced respiratory depression. Within the context of skeletal muscle relaxation, neostigmine and sugammadex are routinely used to reverse the effects of nondepolarizing neuromuscular blocking agents. In addition, the alpha-adrenergic antagonist phentolamine is used in dentistry as a local anesthetic reversal agent, decreasing its duration of action by inducing vasodilation. This review article discusses the pharmacology, uses, practical implications, adverse effects, and precautions needed for flumazenil, naloxone, neostigmine, sugammadex, and phentolamine within the context of sedation and anesthesia practice for dentistry.
Skip Nav Destination
Article navigation
Spring 2022
Research Article|
April 04 2022
Reversal Agents in Sedation and Anesthesia Practice for Dentistry
Michelle Wong, DDS, MSc, EdD
Dental Anesthesiology, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
Address correspondence to Dr Michelle Wong, 124 Edward Street, Suite 256 (M5G 1G6), Toronto, Ontario, Canada.
Search for other works by this author on:
Anesth Prog (2022) 69 (1): 49–58.
Article history
Received:
December 29 2021
Accepted:
February 02 2022
Citation
Michelle Wong; Reversal Agents in Sedation and Anesthesia Practice for Dentistry. Anesth Prog 1 April 2022; 69 (1): 49–58. doi: https://doi.org/10.2344/anpr-69-01-09
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
71
Views
0
Citations
Citing articles via
Cross-sectional Study of PONV Risk Factors for Oral Surgery After Intubated General Anesthesia With Total Intravenous Anesthesia
Emi Ishikawa, DDS, Rie Iwamoto, DDS, PhD, Takayuki Hojo, DDS, PhD, Takahito Teshirogi, DDS, Keiji Hashimoto, DDS, Makiko Shibuya, DDS, PhD, Yukifumi Kimura, DDS, PhD, Toshiaki Fujisawa, DDS, PhD
Prospective Study on PDL Anesthesia as an Aide to Decrease Palatal Infiltration Pain
Brian Crump, DMD, MS, Al Reader, DDS, MS, John Nusstein, DDS, MS, Melissa Drum, DDS, MS, Sara Fowler, DMD, MS, John Draper, PhD
Reversal Agents in Sedation and Anesthesia Practice for Dentistry
Michelle Wong, DDS, MSc, EdD
Severe Bradycardia Occurring After Assisted Mouth Opening: A Case Report
Yoshio Hayakawa, DDS, Keiko Fujii-Abe, DDS, PhD, Takuya Nakano, DDS, PhD, Masayuki Suzuki, DDS, Hiroshi Kawahara, DDS, PhD
Retrograde Intubation Over a Flexible Fiber-Optic Bronchoscope
Ramanjot S. Kang, MD, Robert Hutnik, MD, Ishu Kant, MD, Aaron Zlatopolsky, MD, Chamandeep Brar, DMD, Slawomir P. Oleszak, MD